Related references
Note: Only part of the references are listed.Comparison of Four SARS-CoV-2 Neutralization Assays
Lydia Riepler et al.
VACCINES (2021)
SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme Immunoassays
Gregory J. Walker et al.
VIRUSES-BASEL (2021)
SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19
Jun Wu et al.
NATURE COMMUNICATIONS (2021)
Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance
Suellen Nicholson et al.
OPEN FORUM INFECTIOUS DISEASES (2021)
Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)
Li Guo et al.
CLINICAL INFECTIOUS DISEASES (2020)
Interpreting Diagnostic Tests for SARS-CoV-2
Nandini Sethuraman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Sensitivity in Detection of Antibodies to Nucleocapsid and Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Coronavirus Disease 2019
Peter D. Burbelo et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Biochemical characterization of SARS-CoV-2 nucleocapsid protein
Weihong Zeng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
The receptor-binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients
Lakshmanane Premkumar et al.
SCIENCE IMMUNOLOGY (2020)
Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG
Alexander Krüttgen et al.
JOURNAL OF CLINICAL VIROLOGY (2020)
Quantification of SARS-CoV-2 antibodies with eight commercially available immunoassays
Lisa Weidner et al.
JOURNAL OF CLINICAL VIROLOGY (2020)
Evaluation of Serological Tests for SARS-CoV-2: Implications for Serology Testing in a Low-Prevalence Setting
Katherine Bond et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China
Xin Xu et al.
NATURE MEDICINE (2020)
Evaluation of Orthogonal Testing Algorithm for Detection of SARS-CoV-2 IgG Antibodies
Gang Xu et al.
CLINICAL CHEMISTRY (2020)
IFCC Interim Guidelines on Serological Testing of Antibodies against SARS-CoV-2
Mary Kathryn Bohn et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
Xiangyang Chi et al.
SCIENCE (2020)
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
Philip J. M. Brouwer et al.
SCIENCE (2020)
An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment
Corine H. GeurtsvanKessel et al.
NATURE COMMUNICATIONS (2020)
Comparison of different serological assays for SARS-CoV-2 in real life
Etienne Brochot et al.
JOURNAL OF CLINICAL VIROLOGY (2020)
Humoral Immune Response to SARS-CoV-2 in Iceland
Daniel F. Gudbjartsson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Antibody response to SARS-CoV-2 infection in humans: A systematic review
Nathan Post et al.
PLOS ONE (2020)
Multi-center nationwide comparison of seven serology assays reveals a SARS-CoV-2 non-responding seronegative subpopulation
Kfir Oved et al.
ECLINICALMEDICINE (2020)
Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City
Daniel Stadlbauer et al.
NATURE (2020)
Seroprevalence of antibodies to enterovirus 71 and coxsackievirus A16 among people of various age groups in a northeast province of Thailand
Hatairat Lerdsamran et al.
VIROLOGY JOURNAL (2018)
Amino acids 1055 to 1192 in the S2 region of severe acute respiratory syndrome coronavirus S protein induce neutralizing antibodies: Implications for the development of vaccines and antiviral agents
CT Keng et al.
JOURNAL OF VIROLOGY (2005)